Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.11.21 extracted from

  • Plyte, S.; Musacchio, A.
    PLK1 inhibitors: setting the mitotic death trap (2007), Curr. Biol., 17, R280-R283.
    View publication on PubMed

Application

Application Comment Organism
drug development BI 2536 is well tolerated Mus musculus
drug development roles of Plk1 in cell cycle progression and in mitosis, role for Plk1 in the activation of the CDK1-Cyclin B complex. Plk1 is required not only to obtain, but also to maintain, chromosome bi-orientation on the mitotic spindle, use of BI 2536, a small-molecule inhibitor of Plk1, as an analytical tool and potential cancer therapeutic Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
BI 2536 remarkable potency and selectivity towards Plk1, HeLa cells treated with BI 2536 are first delayed in prophase, after reluctantly entering mitosis, cells become blocked in prometaphase with aberrant monopolar spindles that fail to attach stably to chromosomes Homo sapiens
BI 2536
-
Mus musculus

Organism

Organism UniProt Comment Textmining
Homo sapiens P53350
-
-
Mus musculus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
HeLa cell
-
Homo sapiens
-

Synonyms

Synonyms Comment Organism
Plk1
-
Mus musculus
Plk1
-
Homo sapiens
Polo-like kinase 1
-
Mus musculus
Polo-like kinase 1
-
Homo sapiens